Cefmenoxime

Cefmenoxime
Clinical data

AHFS/Drugs.com	International Drug Names
Routes of administration	Intramuscular, intravenous
ATC code	J01DD05 (WHO)
Pharmacokinetic data
Bioavailability	100% (given IM)
Protein binding	50% to 70%
Metabolism	Negligible
Biological half-life	1 hour
Excretion	Renal, unchanged
Identifiers
IUPAC name (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)- 2-methoxyimino-acetyl]amino}-3-[(1-methyltetrazol- 5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylic acid
CAS Number	65085-01-0^Y
PubChem CID	9570757
DrugBank	DB00267^Y
ChemSpider	7845223^Y
UNII	KBZ4844CXN
KEGG	D07641^Y
ChEBI	CHEBI:55490^Y
ChEMBL	CHEMBL1201224^N
Chemical and physical data
Formula	C₁₆H₁₇N₉O₅S₃
Molar mass	511.562 g/mol
3D model (Jmol)	Interactive image
SMILES O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=N\OC)/c3nc(sc3)N)CSc4nnnn4C)C(=O)O
InChI InChI=1S/C16H17N9O5S3/c1-24-16(20-22-23-24)33-4-6-3-31-13-9(12(27)25(13)10(6)14(28)29)19-11(26)8(21-30-2)7-5-32-15(17)18-7/h5,9,13H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29)/b21-8-/t9-,13-/m1/s1^Y Key:HJJDBAOLQAWBMH-YCRCPZNHSA-N^Y
^NY (what is this?)

Cefmenoxime is a third-generation cephalosporin antibiotic.